•
Sep 30, 2023
•
/

Ascendis Pharma Q3 2023 Earnings Report

Total Revenue
€49.3M
Previous year: €15.6M
+217.0%
EPS
-€2.95
Previous year: -€3.08
-4.0%
Gross Profit
€36.9M
Cash and Equivalents
€455M
Free Cash Flow
-€130M
Total Assets
€873M

Ascendis Pharma

Ascendis Pharma